Skip to Main Content
TRC_PLH
Menu
    • Products
      • CriticalPoint
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • NatMed Advisor
      • NatMed Pro
      • NetCE All Access
      • NetCE All Access: Behaviorial Health
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber Insights
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Featured Charts & Graphics
    • Gender-Related Care
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
    • All Charts & Graphics
  • Podcasts
  • Charts & Graphics
    • Featured Charts & Graphics
    • Diabetes Drugs
    • Do Not Crush List
    • IV Fluid Safety
    • New Drugs
    • Opioid Dosing
    • Vancomycin Dosing
    • All Charts & Graphics >
  • CE/CME & Training
    • CE Organizer
    • Available Courses
    • My Completions
    • Live Webinars
  • Help
    • User Support
    • Contact Us

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

NatMed Pro, the largest natural medicines database, just got a major upgrade! With faster performance, a redesigned interface, and improved navigation, it's easier than ever to find the evidence-based answer you need. Explore Now
Become a smarter pharmacist in minutes! More CE, more resources, more value. Choose your Hospital Pharmacist's Letter membership and elevate your pharmacy practice today. Subscribe Now
  1. Home
  2. Browse
  3. Cardiology
  4. Antithrombotics
  5. Treatment

Treatment

  • Angina (18)
  • Antithrombotics (289)
    • Drug-Induced Thrombosis (28)
    • Prevention (44)
    • Reversal (22)
    • Treatment (264)
      • Apixaban (Eliquis) (100)
      • Aspirin (136)
      • Cangrelor (Kengreal) (4)
      • Clopidogrel (Plavix) (80)
      • Dabigatran (Pradaxa) (101)
      • Edoxaban (Savaysa) (41)
      • Low Molecular Weight Heparins (63)
      • Other (40)
      • Prasugrel (Effient) (42)
      • Rivaroxaban (Xarelto) (110)
      • Ticagrelor (Brilinta) (40)
      • Vorapaxar (Zontivity) (1)
      • Warfarin - Drug Interactions (29)
      • Warfarin - Treatment (120)
  • Arrhythmias (131)
  • Blood Pressure (33)
  • Cardiovascular Disease and Depression (6)
  • Cholesterol (23)
  • CPR (6)
  • Dyslipidemia (168)
  • Endocarditis (21)
  • Heart Disease (84)
  • Heart Failure (155)
  • Hypertension (225)
  • Hypotension (27)
  • Ischemic Heart Disease/Acute Coronary Syndromes (244)
  • Myocardial Infarction (48)
  • Peripheral Vascular Disease (8)
  • Pulmonary Arterial Hypertension (1)
  • Raynaud's (2)
  • Resources (699)
  • Stroke (119)
226 - 240 of 264 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Chart: Comparison of Injectable Anticoagulants August 2012
Other: Warfarin Dose Calculator June 2012
Commentary: Update on Warfarin Dosing and Monitoring June 2012
PL Voices: Warfarin Loading Doses and INR Monitoring June 2012
Commentary: Antiplatelets After Acute Coronary Syndrome or Coronary Stent May 2012
PL Voices: When to Use Vitamin K to Reverse the Anticoagulant Effects of Warfarin May 2012
Guideline: Executive Summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (2012) May 2012
PL Voices: Which Antiplatelet Drug to Add to Aspirin for Acute Coronary Syndrome May 2012
Commentary: Venous Thromboembolism During Travel April 2012
Patient Education: Preventing Blood Clots When You Travel April 2012
Other: Preventing Travel-Related Illnesses April 2012
PL Voices: Does Pradaxa (dabigatran) Increase Heart Attack Risk? March 2012
Commentary: Aspirin for VTE Prophylaxis After Hip or Knee Replacement March 2012
Commentary: VTE Prophylaxis for Medical Inpatients March 2012
Commentary: Dabigatran and Risk of Myocardial Infarction March 2012
  • « Prev
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.



© Therapeutic Research Center. All Rights Reserved